- Home
- ONCY vs VTGN Comparison
ONCY vs VTGN Comparison
Compare ONCY & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- VTGN
- Stock Information
- Founded
- ONCY 1998
- VTGN 1998
- Country
- ONCY Canada
- VTGN United States
- Employees
- ONCY N/A
- VTGN N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- VTGN Health Care
- Exchange
- ONCY Nasdaq
- VTGN Nasdaq
- Market Cap
- ONCY 89.7M
- VTGN 87.2M
- IPO Year
- ONCY 1999
- VTGN N/A
- Fundamental
- Price
- ONCY $1.06
- VTGN $3.22
- Analyst Decision
- ONCY Strong Buy
- VTGN
- Analyst Count
- ONCY 5
- VTGN 0
- Target Price
- ONCY $5.00
- VTGN N/A
- AVG Volume (30 Days)
- ONCY 681.0K
- VTGN 581.7K
- Earning Date
- ONCY 08-08-2025
- VTGN 08-07-2025
- Dividend Yield
- ONCY N/A
- VTGN N/A
- EPS Growth
- ONCY N/A
- VTGN N/A
- EPS
- ONCY N/A
- VTGN N/A
- Revenue
- ONCY N/A
- VTGN $646,000.00
- Revenue This Year
- ONCY N/A
- VTGN $23.83
- Revenue Next Year
- ONCY N/A
- VTGN $660.39
- P/E Ratio
- ONCY N/A
- VTGN N/A
- Revenue Growth
- ONCY N/A
- VTGN N/A
- 52 Week Low
- ONCY $0.33
- VTGN $1.90
- 52 Week High
- ONCY $1.53
- VTGN $3.59
- Technical
- Relative Strength Index (RSI)
- ONCY 54.04
- VTGN 60.10
- Support Level
- ONCY $0.95
- VTGN $3.01
- Resistance Level
- ONCY $1.07
- VTGN $3.26
- Average True Range (ATR)
- ONCY 0.08
- VTGN 0.21
- MACD
- ONCY 0.01
- VTGN -0.01
- Stochastic Oscillator
- ONCY 81.89
- VTGN 55.74
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.